Envista Holdings Corporation (NVST)
| Market Cap | 3.93B +18.7% |
| Revenue (ttm) | 2.88B +9.8% |
| Net Income | 633.60M +4,041.2% |
| EPS | 3.85 +4,373.8% |
| Shares Out | 160.34M |
| PE Ratio | 6.36 |
| Forward PE | 15.14 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,793,407 |
| Open | 24.76 |
| Previous Close | 24.66 |
| Day's Range | 24.48 - 24.98 |
| 52-Week Range | 18.77 - 30.42 |
| Beta | 0.94 |
| Analysts | Buy |
| Price Target | 28.92 (+18.09%) |
| Earnings Date | Nov 4, 2026 |
About NVST
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, ... [Read more]
Financial Performance
Financial StatementsAnalyst Summary
According to 15 analysts, the average rating for NVST stock is "Buy." The 12-month stock price target is $28.92, which is an increase of 18.09% from the latest price.
News
Envista Announces Pricing of $430 Million of Senior Notes
BREA, Calif., Nov. 10, 2026 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that it has priced an offering (the "Offering") of $430 million in aggregate principal...
Envista files automatic mixed securities shelf
08:54 EST Envista (NVST) files automatic mixed securities shelf
Envista price target raised to $29 from $27 at UBS
UBS analyst Kevin Caliendo raised the firm’s price target on Envista (NVST) to $29 from $27 and keeps a Neutral rating on the shares.
Envista price target raised to $30 from $28 at Evercore ISI
Evercore ISI raised the firm’s price target on Envista (NVST) to $30 from $28 and keeps an Outperform rating on the shares.
Envista price target raised to $29 from $26 at Baird
Baird raised the firm’s price target on Envista (NVST) to $29 from $26 and keeps a Neutral rating on the shares. The firm updated its model following mixed Q3 results…
Envista Holdings Earnings Call Transcript: Q3 2026
Q3 core sales rose 2.7%, with adjusted EBITDA up 9% and adjusted EPS up 25%. Full-year 2026 guidance was raised, while China VBP timing and pricing remain key 2027 considerations.
Envista Holdings Earnings release: Q3 2026
Envista Holdings released its Q3 2026 earnings on November 4, 2026, summarizing the period's financial results.
Envista Holdings Slides: Q3 2026
Envista Holdings has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on November 4, 2026.
Envista Holdings Quarterly report: Q3 2026
Envista Holdings has published its Q3 2026 quarterly earnings report on November 4, 2026.
Envista reports Q3 adjusted EPS 40c, consensus 36c
Reports Q3 revenue $691M, consensus $688.73M. “Envista (NVST) delivered another quarter of profitable growth, gaining share and expanding margins,” said Paul Keel, CEO. “Supported by the Envista Busin...
Envista Reports Third Quarter 2026 Results
BREA, Calif., Nov. 4, 2026 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) today announced results for the quarter ended October 2, 2026.
Envista Announces Release of 2025 Sustainability Report
BREA, Calif., Oct. 27, 2026 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced the publication of its 2025 Sustainability Report.
Envista downgraded to Neutral from Outperform at Baird
Baird analyst Jeff Johnson downgraded Envista (NVST) to Neutral from Outperform with a price target of $26, down from $34.
Envista price target lowered to $32 from $35 at Leerink
Leerink lowered the firm’s price target on Envista (NVST) to $32 from $35 and keeps an Outperform rating on the shares. The firm says there are very few expectations for…
Envista price target lowered to $26 from $28 at Piper Sandler
Piper Sandler lowered the firm’s price target on Envista (NVST) to $26 from $28 and keeps a Neutral rating on the shares. The firm is formally updating its Envista model…
Envista Schedules Third Quarter 2026 Earnings Call
BREA, Calif., Oct. 6, 2026 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") will report financial results for its third quarter 2026 on Wednesday, November 4, 2026.
Envista price target lowered to $26 from $29 at BMO Capital
BMO Capital analyst Vik Chopra lowered the firm’s price target on Envista (NVST) to $26 from $29 and keeps a Market Perform rating on the shares. At a conference last…
Envista price target lowered to $27 from $30 at UBS
UBS lowered the firm’s price target on Envista (NVST) to $27 from $30 and keeps a Neutral rating on the shares.
Envista Holdings Transcript: Investor Day 2026
The medium-term outlook rises to 2%-5% core growth, 5%-8% adjusted EBITDA growth and 7%-11% adjusted EPS growth. Product innovation, EBS-led productivity and broader digital workflows underpin the next phase.
Envista Holdings Slides: FY 2026
Envista Holdings has posted slides in relation to its FY 2026 quarterly earnings report, which was published on September 17, 2026.
Envista Holdings Transcript: 2026 Global Healthcare Conference
Leadership highlighted improved financials and market share gains, with consumables and diagnostics leading growth. China’s VBP reforms are causing short-term revenue impacts but are expected to strengthen the company’s position long-term, especially in ortho and implants.
Envista Announces Participation in Baird 2026 Global Healthcare Conference
BREA, Calif., Sept. 8, 2026 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in the Baird 2026 Global Healthcare Conference.
Envista upgraded to Overweight from Neutral at JPMorgan
JPMorgan upgraded Envista (NVST) to Overweight from Neutral with a price target of $32, up from $29, into the investor day on September 17. The firm believes the company is…
Envista price target raised to $23 from $21 at Morgan Stanley
Morgan Stanley raised the firm’s price target on Envista (NVST) to $23 from $21 and keeps an Equal Weight rating on the shares. Envista delivered a solid Q2 beat and…
Envista price target raised to $34 from $31 at Baird
Baird raised the firm’s price target on Envista (NVST) to $34 from $31 and keeps an Outperform rating on the shares. The firm updated its model following Q2 results as…